GPT and metabolic dysfunction-associated steatotic liver disease: In a cohort of NAFLD patients from Hong Kong and France, liver stiffness measurement by FibroScan was accurate for excluding advanced fibrosis (Kleiner stage 3–4) and performed better than non-invasive scores (AST/ALT ratio, APRI, BARD, FIB-4 and NFS)35.